Y Intercept (Hong Kong) LTD Idera Pharmaceuticals, Inc. Transaction History

Y Intercept (Hong Kong) LTD

  • $1.27 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.23 - $0.43 $2,318 - $4,335
-10,082 Closed
0 $0
Q3 2022

Feb 14, 2023
BUY
$0.38 - $0.53 $3,831 - $5,343
10,082 New
10,082 $3,000

Others Institutions Holding IDRA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About IDERA PHARMACEUTICALS, INC.

IDRA Quotes by TradingView
  • Ticker IDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,296,900
  • Market Cap $188M
  • Description
  • Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...
More about IDRA
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email